ABSTRACT
INTRODUCTION
As the number of structures in the RCSB Protein Databank (PDB; Bernstein et al., 1977; Berman et al., 2000) increases, it becomes increasingly difficult for the scientist interested in a given class of proteins to find information on that protein subset. While the PDB web site (http: //www.rcsb.org/) provides simple text-based searches, a search for 'antibody' or 'immunoglobulin' will pull out several non-antibody structures. For example, one is likely to pull out structures where the methods in the header records state that an antibody was used during purification, or all proteins with 'immunoglobulin-like * To whom correspondence should be addressed.
folds'. In addition, information of specific interest in a given research field will not be extracted by a generalpurpose search tool. In the case of antibodies for example, one is likely to be interested in whether the antibody is in complex with antigen, the nature of that antigen and the lengths of the Complementarity Determining Region (CDR) loops. Provision of web-based summaries of data on individual protein classes is one important solution to this problem.
However, any such summary is only useful if it is kept up to date as new structures become available. When only a few tens of structures became available in the PDB each year, the task of keeping such a site up to date manually was not too arduous. However, there are now some 20 new structures appearing every week and manual updating is no longer practical. Automated extraction of data is therefore essential.
Here we describe Summary of Antibody Crystal Structures (SACS), a self-maintaining web-site containing summary information on antibody structures in the PDB.
Antibodies consist of an assembly of four protein chains: two identical 'light' chains of approximately 220 amino acids and two identical 'heavy' chains of approximately 440 amino acids in the most typical IgG class of antibodies. Each chain is divided into domains of approximately 110 amino acids (Padlan, 1994) . In each chain the N-terminal domain has a variable sequence and embodies the specificity for a given antigen. In particular, the hypervariable loops or 'CDRs' (Kabat et al., 1991) , three each from the heavy and light chains, come together in the three-dimensional structure to form the Antigen Combining Site (ACS). The nature of the heavy chain determines the precise function of the antibody. In the IgG class, the third and fourth domains of the two heavy chains come together to form the Fc fragment (Padlan, 1994) responsible for activation of the complement cascade (Reid, 1986) .
The sort of information of interest to workers in the antibody field includes data applicable to any PDB file (date of deposition, experimental method, structure quality, etc.) as well as data specific to antibodies (e.g. light and heavy chain sequence classes, length and sequence of the CDRs, antigen, etc.).
Modern web-based technologies such as eXtensible Markup Language (XML; http://www.w3c.org/XML/) and eXtensible Stylesheet Language: Transformations (XSLT; http://www.w3c.org/TR/xslt/) allow a clear distinction to be made between data content and data presentation. XML is rapidly becoming the de facto standard for structured data storage and contains markup which describes the content. XSLT allows XML to be transformed into any other format, allowing calculations to be performed on the data and individual fields to be selected. XSLT processors generally have specific support for XML and Hypertext Markup Language (HTML) output, but also allow text output which allows generation of simple plain text files, Structured Query Language (SQL, used with relational databases), or any other required format.
METHODS
The PDB data are mirrored locally in Reading using the standard mirroring software (available from ftp://sunsite. org.uk/packages/mirror/mirror.tar.gz). This program creates a local copy of an FTP site and whenever it is run (generally every night), it updates the local copy by downloading only those files which are new or have changed. It allows users to be Emailed automatically when new files are downloaded and, since the Email program to be used can be specified, this mechanism can be co-opted into running any other program.
'Make' (http://www.gnu.org/software/make/) is a program generally used by programmers to build executable programs from a number of source files. This is based on dependencies between files. For example if file B is created from file A using program X, then whenever file A is changed, it is necessary to run program X on file A to regenerate file B. Make automates this procedure, based on a set of user-specified dependency rules, by looking at the time stamps on files.
Mirror is used to run Make whenever new PDB files arrive. The basic Makefile used to process each PDB file in turn is available from the SACS web-site. This may easily be adapted for any task where automated processing of all PDB files is required. Make then automatically identifies new or updated PDB files and runs a Perl script on each of them to identify whether the file is an antibody and if so to extract antibody-related data in XML format. If the PDB file is not an antibody, an empty XML file is generated. Since the time stamp on the XML files (either empty or containing data) is later than that on the PDB file, Make will not rebuild the XML file when run again. Make is also used to call a script which concatenates all individual XML files into a master file containing information on all antibodies. In practice, we use Make to do other processing of PDB files such as calculation of solvent accessibility, secondary structure and hydrogen bonding and extraction of the sequence for use on our internal BLAST server.
Data extraction
Data are extracted from an individual PDB file into an XML file using a script written in Perl. The data extracted and the PDB file records searched are summarized in Table 1 . The reliability of data extraction varies between the fields. For example the PDB code, deposition date, experimental method and resolution of x-ray structures can be identified unambiguously. In contrast, the R-factor in older PDB files, the name of the protein and many of the antibody specific data items (e.g. the sequence class, or name of the antigen) are much more difficult to extract reliably.
The extraction process is made more complicated by having to handle both old and new style PDB files. The newer files are generally easier to parse having less data in purely free text. Since all new files will be in the new format, our efforts have concentrated on parsing the new files correctly.
PDB code. The PDB code is simply extracted from columns 63-66 of the HEADER record. (Column numbers here and below count from column 1.) Deposition date. Similarly the deposition date is extracted from columns 51-59 of the HEADER record. For sorting purposes, the date is also converted to a purely numeric form. To convert the two-digit year to four digits, 1900 is added if the year is greater than 70, otherwise 2000 is added. A numeric date is then calculated according to the simple formula:
where y is the four-digit year, m is the month and d is the day.
Chain assignment. Each chain in the PDB file is assigned as 'light', 'heavy' or 'antigen' by aligning the sequences with consensus light and heavy chain sequences. For each chain, an initial check is made that the sequence is at least 100 amino acids long-shorter chains are assigned as antigen. The sequence is then truncated at 120 residues and is aligned with each of the consensus sequences; the percentage similarity against each is calculated. Initially every chain of more than 100 amino acids is assigned as either light or heavy depending which consensus sequence scores higher. If a chain assigned as light scores less than 79% similarity (using the Dayhoff matrix; Dayhoff et al., 1978) , or a chain assigned as heavy scores less than 85% similarity with the consensus sequence, then it is assigned as a non-antibody chain. All antibody sequences currently in the PDB score better than this and while we may miss a small number of correct assignments in future, we avoid over-assigning and can intervene manually to add information for any unassigned sequences.
Flags are set to indicate PDB files containing only light chains or only heavy chains i.e. to identify light chain dimers (Bence-Jones proteins) or heavy chain dimers (typically from camelids).
New format PDB files divide the COMPND and SOURCE records with MOL ID sub-records describing the properties of each molecule involved. This makes it relatively straightforward to isolate the details for each chain. The chain labels for the first light, heavy and antigen chains are used to find the MOL ID numbers from the COMPND records. This information is then used to extract name and species data for the antibody and antigen from the COMPND and SOURCE records (see Name and Species, below).
Name. The actual name of an antibody is virtually impossible to extract in an automated fashion. For example, in PDB code 2FB4 the commonly used name for this antibody, 'KOL', appears in the SOURCE record (stating that the antibody was extracted from the serum of patient KOL). In more normal examples, such as HyHEL-5, the name appears in the COMPND or HEADER record, but within free text.
Thus short of implementing complex natural language parsing algorithms, we adopt the following procedure. Initially a name for the antibody is created by concatenating columns 11-50 of the HEADER record with columns 11-72 of the TITLE record. If the concatenated string contains only commonly occurring, but non-descriptive words such as IMMUNOGLOBULIN, ANTIBODY, ANTIGEN and COMPLEX, then the COMPND records are concatenated and used instead. With newer PDB files having MOL ID sub-records in the COMPND records, only the appropriate sub-records are concatenated.
Fragment type. The three basic antibody fragment types, FAB, FC and FV are searched for, first in the TITLE record and then in the COMPND and KEYWDS records. As soon as an occurrence of any one of those words is found, the file is assumed to contain that fragment type.
Experimental method, resolution and R-factor. The experimental method (x-ray crystallography, nuclear magnetic resonance, or comparative modelling) is extracted from EXPDTA and REMARK 2 records. For x-ray structures, the resolution is then extracted from the REMARK 2 record.
Obtaining the R-factor is more difficult. With newformat PDB files it is relatively simple to extract from the structured REMARK 3 records, but with older files the R-factor appears in free text and may be specified as 'R-FACTOR', 'R FACTOR', 'R-VALUE', or 'R VALUE' in phrases such as 'the R-value for 7142 reflections between 10.0 and 1.97 Angstroms refinement cycle 73 is 0.254'. A routine previously implemented by one of us (ACRM) as part of the Bioplib library (http://www.bioinf.org.uk/) which makes three passes through the headers to extract this information in a reliable fashion was used.
Complex. We determine whether the structure has been solved as a complex by searching for the keyword COMPLEX in the HEADER, TITLE and COMPND records. A check is made that the string COMPLEX is not a substring of the word UNCOMPLEXED.
Antigen. Identifying the name of the antigen has problems similar to identifying the name of the antibody itself. In new format PDB files where the COMPND records are divided with MOL ID sub-records, the MOL ID of the first antigen chain is identified as described above and it is then relatively straightforward to isolate the details for the antigen.
The COMPND/MOL ID records are themselves split into sub-records. The CHAIN and BIOLOGICAL UNIT sub-records are removed and the remaning information is concatenated into a name for the antigen. In cases where the antigen doesn't exist as a separate chain, the antibody records may contain an OTHER DETAILS subrecord which invariably includes the name of the antigen.
In older PDB files, the name of the antigen often appears in the COMPND records, but may also be found in the HEADER and TITLE records. In these cases, the concatenated COMPND records are examined first and the string following the word COMPLEX is used as a name for the antigen (typically the string will read something like 'immunoglobulin complexed with lysozyme'. If the word COMPLEX is not found in the COMPND records, then the HEADER and TITLE records are concatenated and these are scanned.
Light and heavy chain classes. The light chain class (κ or λ) is identified by searching for the strings KAPPA and LAMBDA in the TITLE records. If not found there, then the HEADER, COMPND and KEYWDS records are also checked. While this works for the majority of cases in which the light chain class is specified, a small number of files simply contain the letter K or L (for example, 'mouse K light chain'). An alternative approach for the light chain would be to align against separate κ and λ consensus sequences.
The heavy chain class is also identified in the TITLE and COMPND records. In this case, the eleven different heavy chains classes identified are: IGM, IGG, IGG1, IGG2, IGG3, IGG4, IGA, IGA1, IGA2, IGE, and IGD. ' * ' characters are removed from the strings first as these are used in, for example, 'IG * G1' to indicate that the second G is always treated as upper case.
Species.
In new format PDB files, the SOURCE records are split into MOL ID sub-records (identified using sequence similarity as described above) and contain ORGANISM SCIENTIFIC sub-records allowing relatively easy identification of the species of the antibody. Older format files contain the species information in free format SOURCE records, but this can be ambiguous in cases such as a mouse antibody bound to hen egg white lysozyme or cases where a mouse antibody has been expressed in bacterial expression systems. In these cases, we err on the side of caution by extracting all information from SOURCE records rather than trying to identify the actual species.
CDR sequence and lengths. The sequence and length of the six CDRs are identified by applying the standard Kabat numbering scheme and using the Kabat boundaries for the CDRs (CDR-L1: L24-L34, CDR-L2: L50-L56, CDR-L3: L89-L97, CDR-H1: H31-H35, CDR-H2: H50-H65, CDR-H3: H95-H102). The sequence for each antibody chain is extracted from the ATOM records of the PDB file and aligned with a consensus sequence using a global Needleman and Wunsch sequence alignment (Needleman and Wunsch, 1970) ; this alignment is used to apply the Kabat numbering.
Identification of light and heavy chains is performed as described above and the chains are treated separately. An earlier approach was to assume that PDB files contain a light chain, followed by a heavy chain, followed by any antigen chains. While this worked for the vast majority of PDB files, a small number contain the antigen before the antibody chains (e.g. 1G9N). Having assigned CDR sequences and lengths, further checks are applied to the sequences and lengths extracted to avoid creating incorrect data. Unusual sequences can result in misalignments and we therefore make a simple check by looking for the sequence Cys-Ala-Arg within CDR-H3. This normally occurs immediately before CDR-H3-if it appears within CDR-H3 an error in the alignment is likely.
Checks on the maximum lengths of the CDRs are also made. Maximum observed CDR lengths were extracted from the Kabat sequence data using KabatMan (Martin, 1996) as follows: CDR-L1 17, CDR-L2 11, CDR-L3 18. CDR-H1 8, CDR-H2 23, CDR-H3 30 and these values were rounded up to: CDR-L1 25, CDR-L2 15, CDR-L3 25. CDR-H1 10, CDR-H2 30, CDR-H3 35. If a loop is found with a length longer than any of these limits then again it is most likely that an error has occurred in the alignment with the consensus sequence.
Data presentation
The individual XML files (one for each PDB file) are concatenated into a single master file. The individual files contain data for those PDB files which have been identified as antibodies but are empty for those which are not. XSLT (using the Sablotron processor, http:// www.gingerall.com) is used to convert the master XML file into a summary web page on-the-fly. The power of XSLT allows us to generate both a page containing oneline summaries of every antibody and detailed pages for individual antibodies from the same XML source file. The detail page includes a link to the PDBSum (http://www. biochem.ucl.ac.uk/bsm/pdbsum/) web page for the PDB file in question which provides more general information on the structure, a direct link to the coordinates for viewing with RasMol and links to other resources including the RCSB PDB web site. XSLT also has the ability to sort the data before presentation and this is used to sort the summary page on PDB code, resolution, CDR length, or deposition date.
RESULTS AND DISCUSSION
The master XML file contains all the <antibody> sections concatenated into a single file and wrapped between <antibodies> and </antibodies> tags and may be downloaded from the SACS web site.
While the data are extracted automatically from PDB files on a daily basis as updates to the PDB occur, some manual intervention is desirable to clean up the automatically extracted text. For example, extracting the name of the antibody is relatively easy, but it will almost invariably be embedded in other text. In the case of PDB file 3HFL, the name is extracted as 'IG * G1 FAB FRAG-MENT (HY/HEL-5) COMPLEXED WITH LYSOZYME (EC. 3.2.1.17)' and this can be manually condensed to 'HyHEL-5'. Critically, the manual intervention is not necessary, but serves to improve the presentation of the data.
The HTML web pages are generated on the fly from the XML. Figures 1 and 2 show part of the summary and detail pages respectively.
An earlier manually maintained list was maintained on the web by one of us (ACRM) and another essentially manual list, updated monthly, has been created by Almagro and co-workers (http: //www.ibt.unam.mx/vir/structure/structures.html). The latter list contains only minimal information (PDB code, name, species, complexed, antigen, experimental details and release date). None of the additional information such as fragment type, class assignments, CDR lengths and sequences, which is of particular interest to those wishing to analyze or model antibodies is present. In addition, our page provides the ability to sort the data on PDB code, deposition date, resolution and the lengths of the six CDRs. As the numbers of structures deposited in the PDB increases it becomes less feasible to maintain such a site manually on a regular basis.
Performance of the method
Our search method based on keywords in the header lines performs extremely well but is not perfect. We have identified three antibodies (PDB codes: 1cu4, 1f2x and 1fl3) found by Almagro, but not found automatically by our method. The reason for this is that the KEYWDS record contains only the phrase 'IMMUNOGLOBULIN FOLD'; such entries are rejected in order to avoid all those structures that are not antibodies, but share the immunoglobulin fold. Every other antibody that has a KEYWDS record contains other keywords such as 'IMMUNOGLOBULIN' or 'ANTIBODY'. The XML for these antibodies is generated by running our data-extraction script manually in 'force' mode where the recognition of whether the structure is an antibody is skipped.
The method also finds 16 false positives. One of these is CD152, an immunoglobulin V-like receptor (PDB code: 1ah1), four are Fc receptors (1als, 1alt, 1e4j and 1h9v), two are MHC Class I natural killer cell immunoglobulin receptors (2dl2 and 2dli), one is Protein-L (light chain binding protein) while the remaining eight (1b03, 1cs9, 1ct6, 1cvq, 1cw8, 1cwz, 1hs0 and 1tos) are all examples of peptide fragments bound to an antibody. In all cases, these examples contain keywords in the headers that one would normally associate with antibody structures. In the case of the eight peptides binding to antibodies, it is very hard even for a human reading the HEADER, TITLE, COMPND and KEYWDS records to recognize that these are not antibodies. The Make-based method that we use means that it is simply necessary to create an empty XML file for these structures to prevent them being processed.
Manual intervention is also necessary in the case of PDB files 1iga and 1nfd where the sequence is rather unusual and the automatic annotation of the CDRs is slightly incorrect (the program warns that the sequences are unusual and manual intervention may be needed). Intervention is also necessary in the case of PDB files 1dvf and 1iai which are both complexes of anti-idiotypic antibodies with the antibodies against which they bind. The automatic extraction provides details only of the first antibody in each file.
In an ideal world, the PDB would contain rigidly formatted records including specific information for protein families. For example, each antibody PDB file would contain records stating explicitly the name of the antibody, its antigen and whether or not the file contains a complex of antibody and antigen. If this were the case, much of the complexity involved in generating the XML would be removed. Indeed, query tools for the whole PDB could be designed to query on and extract data related to specific protein families.
Our automatically generated 'names' for the antibody and antigen are not always as informative as one would wish reflecting these limitations in the PDB format. However, viewing the raw PDB files would not give the user more relevant information than that which we present. Other resources that attempt to extract name information from the PDB in an automated fashion (e.g. PDBSum; http://www.biochem.ucl.ac.uk/bsm/pdbsum) do so no more successfully than we do and our method jumps through several hoops in order to obtain some information of relevance to the researcher. This problem can only be addressed by (a) a major overhaul by the RCSB of PDB files such that these data can be extracted automatically, or (b) by manual curation.
It is our intention to provide manual curation of the files in future. One of the major advantages of our system is that SACS in no way prevents manual curation. The fact that the XML file generated from each PDB file has a later date than the PDB file on which it is built means that it will not be rebuilt when the PDB is updated. Thus if an XML file is hand-modified then it will not be touched by the automatic updating procedure. Thus manual curation is possible, but if it is not done, meaningful information is still presented.
We also attempt to provide information on the light chain class (κ or λ) and heavy chain isotypes (IgA, IgD, IgE, IgG, IgM). Our current methodology provides this annotation only where it is present in the PDB files. Both the issue of correctly identifying antibodies and distinguishing κ and λ light chains may be addressed by comparing sequences against consensus κ, λ and heavy chains. It is our intention to investigate both techniques in a future implementation.
Working with the current version of the PDB involves the use of complex methods to parse the data as used here. An alternative would be to use even more complex natural language parsing Information Extraction (IE) methods (Cowie and Lehnert, 1996; Gaizauskas and Wilks, 1998) .
Comparison with Almagro
The advantages of automation are illustrated by a comparison of our results with the list maintained manually by Almagro. Obviously, manual curation of fields such as the antibody and antigen names has clear advantages. Almagro's web site is updated monthly with the last update, at the time of writing, being February 2001.
The Almagro list contains 364 antibodies currently in the PDB and eight structures listed as obsoleted. One of those listed as obsoleted (1bj1) is not obsolete. At least three obsoleted structures (1fbj, 1fb4 and 3fab) are missing from the obsoleted list and one structure (2osp) is listed as current, but has been obsoleted by 1fj1. There is at least one other error where 1emt is listed as complexed with Buckminsterfullerene, but is actually the free antibody.
In contrast, SACS does not include obsoleted structures. It lists 394 structures in total, 16 of which are Fc fragments (1cqk, 1dn2, 1e4k, 1f6a, 1fc1, 1fc2, 1fcc, 1fp5, 1frt, 1g84, 1i1a, 1ige, 1pfc, 2frt, 2ige and 3fru) which Almagro chooses not to include. Our list thus contains 14 antibody Fab or Fv structures not listed by Almagro. Six of these (1ek3, 1ezv, 1fe8, 1hi6, 1hys, 1il1) have been released by the PDB since their last update, but the other 8 (15c8, 1a8j, 1b6d, 1bww, 1dqd, 1g9m, 1g9n, 1b0w) have dates ranging from March 1998 to January 2001 and have been missed by Almagro.
The Almagro site also presents alignments of the V L and V H amino acids sequences. This is not currently provided by SACS, but may be considered as a future enhancement together with Kabat and Chothia numbering and canonical assignments for each sequence.
Conclusions
This automatically-maintained web-based summary of data on antibodies is an important paradigm in providing appropriate information on individual protein subsets. Obtaining such information directly from the PDB becomes increasingly difficult as the number of structures, both of antibodies and of other proteins, increases. The ability easily to over-ride automatic annotation with manual curation is also critical.
While IE methods and more use of sequence comparison methods, as well as manual curation, may provide some improvements in the data provided, the combination of Mirror, Make, Perl, sequence alignment, XML, XSLT and HTML has proved a very powerful system for creating an automatically updated web site.
Some 500 unique sites have accessed SACS in the first two months since its launch and the resulting web pages can be viewed at http://www.bioinf.org.uk/abs/sacs/ or http://www.rubic.rdg.ac.uk/abs/sacs/
